Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Non-contrast Abbreviated MRI for Secondary Surveillance of Hepatocellular Carcinoma After Curative Treatment: a Prospective Multicenter Study

NCT05690451 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05690451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05690451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Non-contrast Abbreviated MRI for Secondary Surveillance of Hepatocellular Carcinoma After Curative Treatment: a Prospective Multicenter Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
December 28, 2021
Completion date
June 22, 2024
Enrollment
210 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma